We are live on ! Find out more
BAXS

Baxano Surgical
BAXS

Delisted

BAXS was delisted on the 21st of November, 2014.

3 hedge funds and large institutions have $0 invested in Baxano Surgical in 2015 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 6 → 3 (-3)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $2K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
3
Holders Change
-3
Holders Change %
-50%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Texas Yale Capital
Texas Yale Capital
Florida
-$2K

BAXS Hedge Fund Activity: Q1 2015 in Review

3 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Baxano Surgical (BAXS) for Q1 2015, worth a combined $0 — down 100% from $2K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BAXS and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Texas Yale Capital, exiting entirely with an estimated $2K sold.

  • 3 institutional investors held Baxano Surgical (BAXS) as of Q1 2015, down from 6 in Q4 2014.
  • Funds reported $0 of Baxano Surgical stock for Q1 2015, down 100% quarter-over-quarter.
  • 0 funds opened new Baxano Surgical positions in Q1 2015 and 3 closed out, a net change of -3 holders.
  • The largest Baxano Surgical seller in Q1 2015 was Texas Yale Capital, an estimated $2K sold.

Based on aggregated 13F filings for Q1 2015.